S 1302
Increasing Transparency in Generic Drug Applications Act
S 1302 (119th Congress) is federal legislation introduced in the U.S. Senate on April 3, 2025.
Sponsored by Sen. Hassan, Margaret Wood [D-NH].
Current status: Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (2025-04-03).
Summary
Sponsors
person
Sen. Hassan, Margaret Wood [D-NH]
Official Sponsor
Latest Action
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
2025-04-03